- Our Team
- For Patients
- Treatments & Services
- Medical Professionals
Clinical Trial
Clinical Trial Search
Trial Protocol ID USOR 23332_AK117-205
Trial Description
A randomized, double-blind, placebo-controlled, multicenter phase 2 study of AK117/placebo in combination with azacitidine in patients with newly diagnosed higher-risk myelodysplastic syndrome (AK117-205)
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724
Investigator
-
Najeff Waseem, M.D.
Disease Types
Sponsors
- Akeso Biopharma, Inc.
- Tigermed
ClinicalTrials.gov NCT ID
- NCT06196203